A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT07481981 · RECRUITING
Trial details
- NCT number
- NCT07481981
- Sponsor
- Insmed Incorporated
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-21
- Primary completion
- 2028-12-28
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.